Position history for BAILLIE GIFFORD & CO's holdings in DENALI THERAPEUTICS INC
BAILLIE GIFFORD & CO holds 12.1M shares of DNLI (DENALI THERAPEUTICS INC), worth $231.7M as of 2026-Q1. The position was decreased (-2.0% shares). DNLI represents 0.2% of BAILLIE GIFFORD & CO's portfolio.
Current Value
$231.7M
Current Shares
12.1M
Total Value Change
-$87.9M
Total Shares Change
-1.7M
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 12.1M |
-2.0% |
| $231.7M |
| 0.2% |
| $20.02 |
0 |
| 2025-Q4 | Increased | 12.3M | +6.2% | $203.3M | 0.2% | $16.41 | 39 |
| 2025-Q3 | Decreased | 11.6M | -3.0% | $168.3M | 0.1% | $14.52 | 0 |
| 2025-Q2 | Decreased | 12M | -1.1% | $167.3M | 0.1% | $14.10 | 0 |
| 2025-Q1 | Decreased | 12.1M | -1.8% | $164.4M | 0.1% | $14.78 | 0 |
| 2024-Q4 | Decreased | 12.3M | -7.7% | $251M | 0.2% | $20.24 | 0 |
| 2024-Q3 | Decreased | 13.3M | -3.0% | $388.8M | 0.3% | $29.43 | 0 |
| 2024-Q2 | Decreased | 13.8M | -2.0% | $319.6M | 0.2% | $23.22 | 0 |